论文部分内容阅读
1.肝纤维化治疗对象包括大多数慢性肝病患者,病因治疗与抗纤维化治疗同样重要:肝纤维化是存在于许多慢性肝病的共同病理特征,因此大多数慢性肝炎与肝硬化患者都有进行肝纤维化治疗的必要。肝纤维化治疗策略包含去除病因、抗炎症与免疫调节、抑制肝星状细胞(HSC)活化及其胶原代谢、刺激肝细胞再生等多方面,实际是一种广义的抗肝纤维化综合疗法,几乎适合于有慢性肝病,包括慢性病毒性乙型或丙型肝炎、
1. Liver fibrosis The treatment of most patients with chronic liver disease, etiology and anti-fibrosis treatment is equally important: liver fibrosis is present in many chronic liver disease common pathological features, so most of the patients with chronic hepatitis and cirrhosis have been carried out Need for treatment of liver fibrosis. Liver fibrosis treatment strategies include removal of the cause, anti-inflammatory and immune regulation, inhibition of hepatic stellate cells (HSC) activation and collagen metabolism, stimulate liver cell regeneration and many other aspects, in fact, is a generalized anti-liver fibrosis therapy, Almost suitable for chronic liver disease, including chronic viral hepatitis B or C,